Afibrinogenemia: genes and variants
Explore variant evidence for Afibrinogenemia across 3 analyzed proteins (FGB, FGA, FGG). Linked ClinVar records include 9 pathogenic or likely pathogenic variants, 91 variants of uncertain significance and 17 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Afibrinogenemia
FGB: Fibrinogen beta chain
It contributes the beta chains required for assembly and secretion of functional fibrinogen and subsequent fibrin-clot formation. Pathogenic variants can reduce fibrinogen quantity or alter clot properties, producing bleeding, thrombosis, or both.
5 ClinVar pathogenic / likely pathogenic and 21 uncertain variants in FGB have source records linked to Afibrinogenemia. Association strength is not clinical gene validity.
FGA: Fibrinogen alpha chain
It contributes the alpha chains of fibrinogen, which thrombin converts into fibrin to form the structural mesh of blood clots. Pathogenic variants can cause afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia, thrombosis, or certain hereditary amyloidoses.
2 ClinVar pathogenic / likely pathogenic and 68 uncertain variants in FGA have source records linked to Afibrinogenemia. Association strength is not clinical gene validity.
FGG: Fibrinogen gamma chain
It contributes the gamma chains of fibrinogen and provides binding sites important for fibrin polymerization, platelet interactions, and clot stabilization. Pathogenic variants can cause quantitative or qualitative fibrinogen disorders and, in some alleles, hereditary renal amyloidosis.
2 ClinVar pathogenic / likely pathogenic and 19 uncertain variants in FGG have source records linked to Afibrinogenemia. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Afibrinogenemia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| FGG R301H | 301 | Fibrinogen C-terminal | Pathogenic / likely pathogenic (★★) |
| FGG R401W | 401 | Fibrinogen C-terminal | Pathogenic / likely pathogenic (★★) |
| FGA R35C | 35 | Pathogenic / likely pathogenic (★★) | |
| FGA E545V | 545 | Coiled coil | Pathogenic / likely pathogenic (★★) |
| FGB A98T | 98 | Pathogenic / likely pathogenic (★) | |
| FGB L202Q | 202 | Coiled coil | Pathogenic / likely pathogenic |
| FGB G325A | 325 | Fibrinogen C-terminal | Pathogenic / likely pathogenic |
| FGB L383R | 383 | Fibrinogen C-terminal | Pathogenic / likely pathogenic |
| FGB G430D | 430 | Fibrinogen C-terminal | Pathogenic / likely pathogenic |
Which prediction tools work for Afibrinogenemia
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MetaSVM: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 98 out of 100
- PolyPhen-2: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 93 out of 100
- ESM1b (LLR): 78 out of 100
Same protein, different disease
- Familial dysfibrinogenemia also has ClinVar records linked to FGG variants; they fall mostly in different places as the Afibrinogenemia variants (9 pathogenic / likely pathogenic).
Diseases related to Afibrinogenemia
- Hypertrophic cardiomyopathy, also linked to FGA, FGB and FGG
- Noonan syndrome, also linked to FGA, FGB and FGG
- Costello syndrome, also linked to FGA, FGB and FGG
- Familial dysfibrinogenemia, also linked to FGA, FGB and FGG
- Hereditary spastic paraplegia, also linked to FGG
- Deep venous thrombosis, also linked to FGA
- Familial visceral amyloidosis, Ostertag, also linked to FGA
Frequently asked questions
Which genes have records linked to Afibrinogenemia?
This view contains 3 analyzed proteins: FGB, FGA, FGG. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 9 pathogenic or likely pathogenic variants, 91 variants of uncertain significance and 17 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 158 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center